
Adlai Medicine
阿诺医药
Adlai Medicine
Biotech/Healthcare
Adlai Nortye is a clinical-stage global biopharmaceutical company guided by the mission of 'turning cancer into a chronic disease—or even curing it.' It aims to become an innovative R&D enterprise developing 'globally novel' oncology drugs, bringing better treatments to patients in China and around…
Latest round: Series B (2018)
Source: ChinaBulls — chinabulls.com
Last updated 2018-06-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.